SCHEMBL6493952

SCHEMBL6493952

Nc1ccc(-c2nc3c(Cl)c(N)ccc3[nH]2)cc1Cl

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.73
▸ MAPT P10636 8/20 0.73
▸ GAA P10253 7/20 0.73
▸ MEN1 O00255 7/20 0.73
▸ KMT2A Q03164 7/20 0.73
▸ HPGD P15428 7/20 0.73
▸ KDM4E B2RXH2 7/20 0.73
▸ NPC1 O15118 7/20 0.73
▸ RAB9A P51151 7/20 0.73
▸ SMN1; SMN2 Q16637 7/20 0.73
▸ TP53 P04637 4/20 0.73
▸ HSD17B10 Q99714 4/20 0.73
▸ CYP3A4 P08684 3/20 0.73
▸ CACNA1B Q00975 2/20 0.73
▸ APBA1 Q02410 2/20 0.73
▸ NPSR1 Q6W5P4 2/20 0.73
▸ GLA P06280 2/20 0.73
▸ CYP1A2 P05177 1/20 0.73
▸ CYP2C9 P11712 1/20 0.73
▸ CYP2C19 P33261 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6494910 0.84 MEN1 (1.00) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL6483416 0.78 ALDH1A1 (0.79) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL6482060 0.77 RPS6KA3 (0.64) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL6483072 0.77 ALDH1A1 (0.50) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL6483081 0.77 ALDH1A1 (0.50) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL6493950 0.76 ALDH1A1 (0.63) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL6483421 0.75 MEN1 (1.00) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL5354818 0.71 ALDH1A1 (0.54) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL6507007 0.70 ALDH1A1 (0.57) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL28257886 0.70 RPS6KA3 (0.73) ALDH1A1MAPTGAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein BF RESEARCH INSTITUTE (JP) 2005-11-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein PRNP, PRPH, PCNP ALDH1A1 1577/4885MAPT 7/4885GAA 381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback